Mohammed Elhassan Shaza, Charlson Mary, Jama Hibaq, Zakri Farhan, Elajez Reem Hassan, Ahmed Fayeha, Taheri Shahrad
Department of General Pediatrics, Hamad Medical Corporation, Doha, Qatar.
Division of Clinical Epidemiology and Evaluative Sciences Research, Weill Cornell Medicine, New York, New York, USA.
BMJ Paediatr Open. 2017 Oct 25;1(1):e000077. doi: 10.1136/bmjpo-2017-000077. eCollection 2017.
Allergies are a growing health concern with a significant impact on quality of life and healthcare costs. It is critical to develop an appropriate care plan to deal with children's allergies. This study aimed to assess and compare the knowledge and perception of families and school personnel caring for children with history of anaphylaxis who were prescribed the epinephrine autoinjector (EpiPen). The study also examined the underlying reasons for any observed knowledge gaps.
A cross-sectional study of 128 families and 50 corresponding school personnel caring for children at risk of anaphylaxis who had been prescribed the EpiPen was conducted. The primary outcome was to identify any knowledge deficiency within family and school personnel and the reasons behind knowledge gaps.
Of the 128 screened schools, 30 (23%) were not informed by parents about their pupils' risk of anaphylaxis. Importantly, 113 (88%) of families and 42 (84%) of schools were unable to recognise the symptoms of anaphylaxis. Also, 67 (52%) of families and 22 (44%) of schools were not aware that a child should ideally have two EpiPen in case of a severe allergic reaction. The EpiPen had been used by 18 (14%) families and 5 (6%) schools.
Communication among families and school personnel regarding anaphylaxis was suboptimal. Both parents and school personnel lacked key information in allergy management. Managing a child at risk of anaphylaxis requires effective communication among healthcare professionals, families and schools. There is an urgent need to improve knowledge of anaphylaxis and its management among families and school caregivers.
过敏问题日益受到健康关注,对生活质量和医疗成本产生重大影响。制定适当的护理计划来应对儿童过敏至关重要。本研究旨在评估和比较照顾有过敏反应病史且已开具肾上腺素自动注射器(EpiPen)的儿童的家庭和学校工作人员的知识与认知。该研究还调查了所观察到的知识差距的潜在原因。
对128个家庭和50名相应的学校工作人员进行了一项横断面研究,这些人员照顾的儿童有过敏反应风险且已开具EpiPen。主要结果是确定家庭和学校工作人员中存在的任何知识缺陷以及知识差距背后的原因。
在128所筛查的学校中,有30所(23%)未被家长告知其学生有过敏反应风险。重要的是,113个(88%)家庭和42所(84%)学校无法识别过敏反应的症状。此外,67个(52%)家庭和22所(44%)学校不知道孩子在发生严重过敏反应时理想情况下应该有两支EpiPen。18个(14%)家庭和5所(6%)学校使用过EpiPen。
家庭和学校工作人员之间关于过敏反应的沟通不理想。家长和学校工作人员在过敏管理方面都缺乏关键信息。管理有过敏反应风险的儿童需要医疗专业人员、家庭和学校之间进行有效的沟通。迫切需要提高家庭和学校护理人员对过敏反应及其管理的认识。